Multi-omics assist in designing the next generation of COVID-19 therapeutics and vaccines

The ongoing COVID-19 pandemic has raised global concern on public health. There are major challenges ahead to develop new therapeutics and vaccines for difficult-to-target pathogens, for which we urgently need a better understanding of protective immunity. The development of high-throughput sequencing, mass spectrometry, computer science and algorithms provide us with a comprehensive and systematic picture of life processes, and enhance our understanding of human immunity and diseases.